Med. praxi. 2019;16(1):14-19 | DOI: 10.36290/med.2019.003

What are the changes brought by the new CSH guidelines?

prof. MUDr. Miroslav Souček, CSc.
II. interní klinika a ICRC FN u sv. Anny v Brně a LF MU

Since the latest Czech Society of Hypertension (CSH) guidelines were published five years ago, there has been an opinion shift on
some issues concerning the diagnosis and treatment of hypertension, which is a reason for issuing new guidelines. (1) This document
aims to summarize the current knowledge based on the results of the most recent trials and show what is new compared
with the previous version. This article deals with some chapters where changes have been made.

Keywords: hypertension, new guidelines, target of treatment, adherence to treatment

Published: February 25, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Souček M. What are the changes brought by the new CSH guidelines? Med. praxi. 2019;16(1):14-19. doi: 10.36290/med.2019.003.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Filipovský J, Widimský J jr., Ceral J, et al. Diagnostické a léčebné postupy u arteriální hypertenze-verze 2012. Doporučení České společnosti pro hypertenzi. Vnitřní lékařství 2012; 58: 785-801. Go to PubMed...
    2. Praktický postup České společnosti pro hypertenzi: Měření krevního tlaku 1. část: Obecné principy. Linhart A, Ceral J, Filipovský J. Hypertenze a KV prevence 2016/2, 24-27. Viz též www.hypertension.cz
    3. Praktický postup České společnosti pro hypertenzi: Měření krevního tlaku 2. část: Měření krevního tlaku v ordinaci Ceral J, Linhart A, Filipovský J. Hypertenze a KV prevence 2016/2, 28-33. Viz též www.hypertension.cz
    4. Filipovský J, Seidlerová J, Kratochvíl Z, Karnosová P, Hronová M, Mayer O Jr. Blood Press. 2016; 25(4): 228-234. Automated compared to manual office blood pressure and to home blood pressure in hypertensive patients. Go to original source... Go to PubMed...
    5. Conen D, Aeschbacher S, Thijs L, et al. Age-Specific Differences Between Conventional and Ambulatory Daytime Blood Pressure Values. Hypertension 2014; 64: 1073-1079. Go to original source...
    6. Mancia G, Bombelli M, Cuspidi C, Facchetti R, Grassi G. Cardiovascular risk associated with white-coat hypertension. Pro Side of the Argument. Hypertension 2017; 70: 668-675. Go to original source... Go to PubMed...
    7. Mancia G, Bombelli M, Facchetti R, et al. Long-term risk of sustained hypertension in white-coat or masked hypertension. Hypertension 2009; 54: 226-232. Go to original source... Go to PubMed...
    8. Mancia G, Bombelli M, Facchetti R, et al. Increased long-term risk of new-onset diabetes mellitus in white-coat and masked hypertension. J Hypertension 2009; 27: 1672-1678. Go to original source... Go to PubMed...
    9. Sundstrom J, Neovius M, Tynelius P, Rasmussen F. Association of blood pressure in late adolescence with subsequent mortality: cohort study of Swedish male conscripts. BMJ 2011; 342: d643. Go to original source... Go to PubMed...
    10. Grebla RC, Rodriguez CJ, Borrell LN, Pickering TJ. Prevalence and determinants of isolated systolic hypertension among young adults: the 1999-2004 US National Health And Nutrition Examination Survey. J Hypertens 2010; 28: 15-23.
    11. McEniery CM, Yasmin, Wallace S, et al. ENIGMA Study Investigators. Increased stroke volume and aortic stiffness contribute to isolated systolic systolic hypertension in young adults. Hypertension 2005; 46: 221-226. Go to original source... Go to PubMed...
    12. The SPRINT Research Group A Randomized Trial of Intensive versus Standard Blood-Pressure Control N Engl J Med 2015; 373: 2103-2116.
    13. Olde Engberink RH, Frenkel WJ, van den Bogaard B, et al. Effects of thiazide-type and thiazide-like diuretics on cardiovascular events and mortality: systematic review and meta-analysis. Hypertension 2015; 65: 1033-1040. Go to original source...
    14. Roush GC, Ernst ME, Kostis JB, Tandon S, Sica DA. Head-to-head comparisons of hydrochlorothiazide with indapamide and chlorthalidone: antihypertensive and metabolic effects. Hypertension 2015; 65: 1041-1046. Go to original source...
    15. Matsuzaki M, Ogihara T, Umemoto S, et al. Prevention of cardiovascular events with calcium channel blocker-based combination therapies in patients with hypertension: a randomised controlled trial. J Hypertens 2011; 29: 1649-1659. Go to original source...
    16. Yusuf S, Teo KK, Pogue J, et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 2008; 358: 1547-1559. Go to original source...

    Return to the content


    Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.